Ribosome inactivating proteins from plants inhibiting viruses

Area of Science:

• Biochemistry
• Virology
• Molecular Biology

Background:

• Plants produce ribosome inactivating proteins (RIPs) with N-glycosidase activity.
• RIPs depurinate ribosomal RNA, inhibiting protein synthesis and showing broad antiviral effects.
• RIPs have demonstrated efficacy against viruses like HIV, HBV, and HSV.

Purpose of the Study:

• To review plant-derived RIPs with anti-HIV activity.
• To explore the mechanisms of RIPs' antiviral action.
• To highlight the clinical potential of RIPs in HIV treatment.

Main Methods:

• Literature review of studies on plant-derived RIPs.
• Analysis of RIPs' enzymatic activity and antiviral mechanisms.
• Examination of clinical trial data for RIPs in HIV therapy.

Main Results:

• RIPs inhibit viral replication by depurinating rRNA, viral RNA, and DNA.
• Antiviral mechanisms may involve host cell ribosome inactivation, viral protein translation inhibition, and host cell death.
• Phase I/II clinical trials indicate RIPs' potential for treating HIV disease.

Conclusions:

• Plant-derived RIPs possess significant antiviral properties, particularly against HIV.
• Understanding RIPs' precise antiviral mechanisms is crucial for therapeutic development.
• RIPs represent a promising area for novel anti-HIV drug discovery.